Skip to main content

PT-141 Application

Meaning

PT-141 application refers to the clinical use of Bremelanotide, a synthetic peptide and potent agonist of the melanocortin receptors, specifically MC3R and MC4R, for the treatment of hypoactive sexual desire disorder (HSDD). This therapeutic agent is administered via subcutaneous injection or nasal spray to modulate central nervous system pathways that govern sexual arousal and desire. Its application is distinct from traditional vasoactive agents, as it targets the neurochemical basis of sexual function rather than peripheral blood flow mechanics. Careful patient selection and counseling are integral to its appropriate clinical integration.